Opportunity ID: 328940

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-024
Funding Opportunity Title: HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 03, 2020
Last Updated Date: Sep 03, 2020
Original Closing Date for Applications: Mar 15, 2023
Current Closing Date for Applications: Mar 15, 2023
Archive Date: Apr 20, 2023
Estimated Total Program Funding:
Award Ceiling: $2,500,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
County governments
For profit organizations other than small businesses
Small businesses
Special district governments
Native American tribal governments (Federally recognized)
City or township governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-024.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 328940 Full Announcement-PAR-21-024 -> PAR-21-024-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00263231 Feb 15, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269935 Oct 29, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277487 Oct 27, 2022 Mar 15, 2023 View

Package 1

Mandatory forms

328940 RR_SF424_2_0-2.0.pdf

328940 PHS398_CoverPageSupplement_5_0-5.0.pdf

328940 RR_OtherProjectInfo_1_4-1.4.pdf

328940 PerformanceSite_2_0-2.0.pdf

328940 RR_KeyPersonExpanded_2_0-2.0.pdf

328940 PHS398_ResearchPlan_4_0-4.0.pdf

328940 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

328940 PHS_Additional_IndirectCosts-1.0.pdf

328940 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

328940 RR_SF424_5_0-5.0.pdf

328940 PHS398_CoverPageSupplement_5_0-5.0.pdf

328940 RR_OtherProjectInfo_1_4-1.4.pdf

328940 PerformanceSite_4_0-4.0.pdf

328940 RR_KeyPersonExpanded_4_0-4.0.pdf

328940 PHS398_ResearchPlan_4_0-4.0.pdf

328940 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

328940 PHS_Additional_IndirectCosts_2_0-2.0.pdf

328940 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

328940 RR_SF424_5_0-5.0.pdf

328940 PHS398_CoverPageSupplement_5_0-5.0.pdf

328940 RR_OtherProjectInfo_1_4-1.4.pdf

328940 PerformanceSite_4_0-4.0.pdf

328940 RR_KeyPersonExpanded_4_0-4.0.pdf

328940 PHS398_ResearchPlan_5_0-5.0.pdf

328940 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

328940 PHS_Additional_IndirectCosts_2_0-2.0.pdf

328940 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T15:01:05-05:00

Share This Post, Choose Your Platform!

About the Author: